![Towards the development of Self-Nano-Emulsifying Drug Delivery Systems (SNEDDS) containing trimethyl chitosan for the oral delivery of amphotericin B: In vitro assessment and cytocompatibility studies - ScienceDirect Towards the development of Self-Nano-Emulsifying Drug Delivery Systems (SNEDDS) containing trimethyl chitosan for the oral delivery of amphotericin B: In vitro assessment and cytocompatibility studies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1773224719316491-fx1.jpg)
Towards the development of Self-Nano-Emulsifying Drug Delivery Systems (SNEDDS) containing trimethyl chitosan for the oral delivery of amphotericin B: In vitro assessment and cytocompatibility studies - ScienceDirect
![Ioannis Kalinderis's research works | Aristotle University of Thessaloniki, Thessaloníki (AUTH) and other places Ioannis Kalinderis's research works | Aristotle University of Thessaloniki, Thessaloníki (AUTH) and other places](https://www.researchgate.net/profile/Fotis-Maris/publication/257198280/figure/fig5/AS:650788179283976@1532171401901/Overall-model-for-processing-the-Universal-Soil-Loss-Equation_Q320.jpg)
Ioannis Kalinderis's research works | Aristotle University of Thessaloniki, Thessaloníki (AUTH) and other places
![Development and Characterization of a Self-Nanoemulsifying Drug Delivery System Comprised of Rice Bran Oil for Poorly Soluble Drugs | SpringerLink Development and Characterization of a Self-Nanoemulsifying Drug Delivery System Comprised of Rice Bran Oil for Poorly Soluble Drugs | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1208%2Fs12249-018-1274-y/MediaObjects/12249_2018_1274_Fig1_HTML.png)
Development and Characterization of a Self-Nanoemulsifying Drug Delivery System Comprised of Rice Bran Oil for Poorly Soluble Drugs | SpringerLink
![HPLC chromatogram of topical cream stress testing at 40 °C ± 2/75% ± 5... | Download Scientific Diagram HPLC chromatogram of topical cream stress testing at 40 °C ± 2/75% ± 5... | Download Scientific Diagram](https://www.researchgate.net/publication/343366058/figure/fig4/AS:922152744263680@1596869755386/HPLC-chromatogram-of-topical-cream-stress-testing-at-40-C-2-75-5-RH-after-6-months.png)
HPLC chromatogram of topical cream stress testing at 40 °C ± 2/75% ± 5... | Download Scientific Diagram
![IJMS | Free Full-Text | Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer IJMS | Free Full-Text | Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer](https://www.mdpi.com/ijms/ijms-24-05954/article_deploy/html/images/ijms-24-05954-g002-550.jpg)
IJMS | Free Full-Text | Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer
![IJMS | Free Full-Text | Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer IJMS | Free Full-Text | Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer](https://www.mdpi.com/ijms/ijms-24-05954/article_deploy/html/images/ijms-24-05954-g001.png)
IJMS | Free Full-Text | Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer
![IJMS | Free Full-Text | Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer IJMS | Free Full-Text | Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer](https://www.mdpi.com/ijms/ijms-24-05954/article_deploy/html/images/ijms-24-05954-g003-550.jpg)
IJMS | Free Full-Text | Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer
![Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation - ScienceDirect Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168365918301688-fx1.jpg)
Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation - ScienceDirect
![IJMS | Free Full-Text | Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer IJMS | Free Full-Text | Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer](https://pub.mdpi-res.com/ijms/ijms-24-05954/article_deploy/html/images/ijms-24-05954-g004.png?1679447056)
IJMS | Free Full-Text | Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer
![A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit | SpringerLink A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00262-015-1717-1/MediaObjects/262_2015_1717_Fig1_HTML.gif)
A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit | SpringerLink
![Ioannis Kalinderis's research works | Aristotle University of Thessaloniki, Thessaloníki (AUTH) and other places Ioannis Kalinderis's research works | Aristotle University of Thessaloniki, Thessaloníki (AUTH) and other places](https://www.researchgate.net/profile/Fotis-Maris/publication/257198280/figure/fig1/AS:650788179279874@1532171401315/The-research-area-a-the-dam-of-Louros-b-Abb-1-Das-Untersuchungsgebiet-a-der_Q320.jpg)